Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions

NCT02360423 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: CRE8 sirolimus-eluting stent
DEVICE: RESOLUTE zotarolimus-eluting stent

Sponsor

CID S.p.A.